文献速递瘢痕与激光创面修复

人脂肪干细胞来源细胞外囊泡预防兔增生性瘢痕形成

Extracellular Vesicles Derived From Human Adipose-Derived Stem Cell Prevent the Formation of Hypertrophic Scar in a Rabbit Model.
PubMed 文献 · Ann Plast Surg · 2020-01-01

该研究在兔耳创面模型上比较人脂肪干细胞来源细胞外囊泡(hASC-EVs)与去除EV的条件培养基对增生性瘢痕形成的作用。结果显示创面愈合期局部注射hASC-EVs可预防增生性瘢痕形成并抑制胶原沉积与肌成纤维细胞聚集,而去除EV的条件培养基无此效果,提示hASC的防瘢痕作用主要经旁分泌EV而非细胞因子实现。

要点

  • 兔耳创面局部注射hASC-EVs可预防增生性瘢痕形成。
  • hASC-EVs抑制胶原沉积与肌成纤维细胞聚集。
  • 去除EV的条件培养基无防瘢痕作用,提示EV是关键。

核心结论

  • hASC的预防瘢痕形成作用与旁分泌EV相关而非细胞因子。
  • 创面愈合期局部注射hASC-EVs可有效预防兔耳增生性瘢痕形成。

研究设计与样本

  • 采用兔瘢痕模型:16只新西兰兔双耳腹侧制作直径8 mm创面。
  • 右耳创面局部注射0.1 mL hASC-EV或去除EV的条件培养基,左耳注射等量磷酸缓冲盐溶液作对照。
  • hASCs取自健康女性供者皮下脂肪组织,取第3–5代培养上清分离EV与去除EV条件培养基。
  • EV经透射电镜、NanoSight及Western blotting(CD63、TSG101、Alix)表征;去除EV条件培养基经Western blotting检测VEGFA、PDGFB、TGFβ1。
  • 术后第28天取创面及周围组织行H&E、Masson及α-SMA免疫荧光染色,并以Western blotting评估α-SMA与I型胶原蛋白表达。

主要发现

  • hASCs高表达49d、CD90、CD105、CD73,不表达CD34与CD45。
  • hASC-EVs为圆形双层膜囊泡,约95%颗粒粒径在50–200 nm之间。
  • hASC-EVs表达CD63、TSG101、Alix,VEGFA、PDGFB、TGFβ1表达低。
  • 去除EV条件培养基高表达VEGFA、PDGFB、TGFβ1,不表达CD63、TSG101、Alix。
  • 术后第28天hASC-EV组预防增生性瘢痕形成并抑制胶原沉积与肌成纤维细胞聚集;去除EV条件培养基组与对照组相比无此效果。

临床怎么用

  • 创面愈合期局部注射hASC-EVs可能作为预防增生性瘢痕的候选策略。
  • hASC条件培养基的防瘢痕作用主要归因于EV而非其中的细胞因子。

局限性

  • 研究为兔耳动物模型,样本为16只新西兰兔,结论外推至人需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preventing scar formation during wound healing has important clinical implications. Numerous studies have indicated that adipose-derived stem cell culture mediums, which are rich in cytokines and extracellular vesicles (EVs), regulate matrix remodeling and prevent scar formation after wound healing. Therefore, using a rabbit scar model, we tried to demonstrate which factor in adipose-derived stem cell culture mediums plays a major role in preventing scar formation (EVs or cytokines), as well as revealing the underlying mechanism. METHODS: Human adipose-derived stem cells (hASCs) were isolated from the subcutaneous adipose tissue of a healthy female donor. The surface CD markers of third-passage hASCs were analyzed by flow cytometry. The adipogenic differentiation capacity of the hASCs was detected using Oil O staining. A cultured medium of third- to five-passage hASCs was collected for EV and EV-free medium isolations. Extracellular vesicles were characterized using transmission electron microscopy, NanoSight, and the Western blotting for surface markers CD63, TSG101, and Alix. The EV-free medium was characterized by Western blotting for vascular endothelial growth factor A (VEGFA), platelet derived growth factor B (PDGFB), and transforming growth factor β 1 (TGFβ1). Eight-millimeter-diameter wounds were created on the ventral side of both ears of 16 New Zealand rabbits. A total of 0.1 mL of the human adipose-derived stem cell-extracellular vesicle (hASC-EV) or EV-free medium was locally injected into wounds made on the right ears during wound healing. Meanwhile, equal amounts of phosphate buffer saline were injected into the left ears as a control. Biopsies of the wounded skin and surrounding tissue were excised on postoperative day 28 and subjected to hematoxylin and eosin (H&E), Masson, and α-SMA immunofluorescence staining. The protein expression of α-SMA and collagen I in both scar tissues and the normal skin were evaluated via Western blotting. RESULTS: The hASCs expressed high levels of 49d, CD90, CD105, and CD73 but did not express CD34 or CD45. The hASCs differentiated into adipocytes under an adipogenic induction medium. Under transmission electron microscopy, the hASC-EVs were circular, bilayer membrane vesicles and approximately 95% of the particles were between 50 and 200 nm in size. The hASC-EVs expressed the same surface markers as EVs, including CD63, TSG101, and Alix and displayed little expression of VEGFA, PDGFB, and TGFβ1. The EV-free medium had a high expression of VEGFA, PDGFB, and TGFβ1 but displayed no expression of CD63, TSG101, and Alix. In vivo, the hASC-EV treatment prevented the formation of hypertrophic scars on postoperative day 28 and suppressed collagen deposition and myofibroblast aggregation. However, the EV-free medium did not prevent the formation of hypertrophic scars on the same time point and had little effect on collagen deposition and myofibroblast aggregation when compared with the control group. CONCLUSIONS: Our study suggests that hASCs are associated with preventive scar formation therapy because of paracrine EVs rather than cytokines. A local injection of hASC-EVs during wound healing efficiently prevented hypertrophic scar formation, which may have a clinically beneficial antiscarring effect.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Zhu YZ, Hu X, Zhang J, et al. Extracellular Vesicles Derived From Human Adipose-Derived Stem Cell Prevent the Formation of Hypertrophic Scar in a Rabbit Model. Ann Plast Surg. 2020. PMID: 32282497. doi:10.1097/SAP.0000000000002357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。